The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Thyroid Hormone Regulation and Cholesterol Metabolism Are Connected through Sterol Regulatory Element-binding Protein-2 (SREBP-2)
Open accessAbstract
High affinity uptake of serum-derived low density lipoprotein (LDL) cholesterol is accomplished through the LDL receptor in the liver. In mammals, thyroid hormone depletion leads to decreased LDL receptor expression and elevated serum cholesterol. The clinical association in humans has been known since the 1920s; however, a molecular explanation has been lacking. LDL receptor levels are subject to negative feedback regulation by cellular cholesterol through sterol regulatory element-binding protein-2 (SREBP-2). Here we demonstrate that the SREBP-2 gene is regulated by thyroid hormone and that increased SREBP-2 nuclear protein levels in hypothyroid animals results in thyroid hormone-independent activation of LDL receptor gene expression and reversal of the associated hypercholesterolemia. This occurs without effects on other thyroid hormone-regulated genes. Thus, we propose that the decreased LDL receptor and increased serum cholesterol associated with hypothyroidism are secondary to the thyroid hormone effects on SREBP-2. These results suggest that hypercholesterolemia associated with hypothyroidism can be reversed by agents that directly increase SREBP-2. Additionally, these results indicate that mutations or drugs that lower nuclear SREBP-2 would cause hypercholesterolemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11041 · Cited by 1,134
Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., Goldstein, J. L., & Brown, M. S. (1993) · Cell · doi:10.1016/0092-8674(93)90690-r · Cited by 981
Differential Recognition of Target Genes by Nuclear Receptor Monomers, Dimers, and Heterodimers*
GLASS, C. K. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-391 · Cited by 829
Duntas, L. H. (2002) · Thyroid · doi:10.1089/10507250252949405 · Cited by 725
Determinants for selective RAR and TR recognition of direct repeat HREs.
Perlmann, T., Rangarajan, P. N., Umesono, K., & Evans, R. M. (1993) · Genes & Development · doi:10.1101/gad.7.7b.1411 · Cited by 400
Cited by
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Thyroid Hormone Action in the Heart
Kahaly, G. J., & Dillmann, W. H. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0033 · Cited by 717
Direct effects of thyroid hormones on hepatic lipid metabolism
Sinha, R. A., Singh, B. K., & Yen, P. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.10 · Cited by 660
Thyroid dysfunction and diabetes mellitus: two closely associated disorders
Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00163 · Cited by 598
SREBPs: metabolic integrators in physiology and metabolism
Jeon, T.-I., & Osborne, T. F. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.10.004 · Cited by 464
Self-citationEffects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M. S., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 392
Im, S.-S., Yousef, L., Blaschitz, C., Liu, J. Z., Edwards, R. A., Young, S. G., Raffatellu, M., & Osborne, T. F. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.001 · Cited by 357
Self-citationCholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases
Song, Y., Liu, J., Zhao, K., Gao, L., & Zhao, J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.001 · Cited by 322
Sinha, R. A., Bruinstroop, E., Singh, B. K., & Yen, P. M. (2019) · Thyroid · doi:10.1089/thy.2018.0664 · Cited by 271
Update in Lipid Alterations in Subclinical Hypothyroidism
Pearce, E. N. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2532 · Cited by 269
The Effect of Thyroid Disorders on Lipid Levels and Metabolism
Duntas, L. H., & Brenta, G. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.012 · Cited by 258
Osborne, T. F., & Espenshade, P. J. (2009) · Genes & Development · doi:10.1101/gad.1854309 · Cited by 238
Self-citationThyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation
Liu, Y.-Y., & Brent, G. A. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.004 · Cited by 218
Thyroid hormone signaling and the liver
Ritter, M. J., Amano, I., Hollenberg, A. N., et al. (2020) · Hepatology · doi:10.1002/hep.31296 · Cited by 188
“(28,34,35) This is thought to be from two mechanisms— direct regulation through TR recruitment to the LDL-R promoter, where TREs are located, and indirect by activation of Srebp2, which then activates the LDL-R.(36,37) TH administration rapidly lowers cholesterol levels, and treating hypothyroidism lowers cholesterol…”
BackgroundActivation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez, D., Abisambra Socarrás, J. F., Bedi, M., & Ness, G. C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.05.001 · Cited by 109
Flock, M. R., Green, M. H., & Kris-Etherton, P. M. (2011) · Advances in Nutrition · doi:10.3945/an.111.000422 · Cited by 82
Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway
Goldberg, I. J., Huang, L.-S., Huggins, L. A., Yu, S., Nagareddy, P. R., Scanlan, T. S., & Ehrenkranz, J. R. (2012) · Endocrinology · doi:10.1210/en.2012-1572 · Cited by 80
The Lipoprotein Lipase Inhibitor ANGPTL3 Is Negatively Regulated by Thyroid Hormone
Fugier, C., Tousaint, J.-J., Prieur, X., Plateroti, M., Samarut, J., & Delerive, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512554200 · Cited by 60
PCSK9 in metabolism and diseases
Ajoolabady, A., Pratico, D., Mazidi, M., Davies, I. G., Lip, G. Y. H., Seidah, N., Libby, P., Kroemer, G., & Ren, J. (2025) · Metabolism · doi:10.1016/j.metabol.2024.156064 · Cited by 49
Witte, T., Ittermann, T., Thamm, M., Riblet, N. B. V., & Völzke, H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4466 · Cited by 46
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis
Wirth, E. K., Puengel, T., Spranger, J., & Tacke, F. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2110864 · Cited by 42
Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model
Pietzner, M., Engelmann, B., Kacprowski, T., Golchert, J., Dirk, A.-L., Hammer, E., Iwen, K. A., Nauck, M., Wallaschofski, H., Führer, D., et al. (2017) · BMC Medicine · doi:10.1186/s12916-016-0770-8 · Cited by 40
Functional Peroxisomes Are Essential for Efficient Cholesterol Sensing and Synthesis
Charles, K. N., Shackelford, J. E., Faust, P. L., Fliesler, S. J., Stangl, H., & Kovacs, W. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.560266 · Cited by 36
“Normally, SCAP is retrieved from the Golgi and moves back to the ER by COPI-mediated Golgi-to-ER retrograde trafficking after processing of SREBP under sterol-deficient conditions (Takashima et al., 2015).”
BackgroundThyroid hormone analogs for the treatment of dyslipidemia: past, present, and future
Delitala, A. P., Delitala, G., Sioni, P., & Fanciulli, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1330259 · Cited by 29
Novel strategies for managing dyslipidemia: treatment beyond statins
Ling, H., Burns, T. L., & Hilleman, D. E. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2612 · Cited by 10
Retnakaran, R., Connelly, P. W., & Goguen, J. (2005) · Endocrine Practice · doi:10.4158/ep.11.6.394 · Cited by 8
Metadata
- Authors
- Shin, D.-J., & Osborne, T. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 278
- Issue
- 36
- Pages
- 34114-34118
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2064595979
- Cited by
- 266
- References
- 34
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.